
Cizzle Bio Debuts Early Lung Cancer Blood Test in Texas
Texas-based Cizzle Bio has launched its proprietary CIZ1B biomarker blood test for lung cancer, marking the first phase of its U.S. commercial strategy. The diagnostic tool is now available to licensed health care providers across Dallas-Fort Worth and San Antonio, targeting earlier detection of the disease.



























